1,4-bis(3-aminopropyl)piperazine libraries: from the discovery of classical chloroquine-like antimalarials to the identification of new targets. 2005

Rébecca Deprez-Poulain, and Patricia Melnyk
Laboratoire de Chimie Générale et Bioinorganique, UMR CNRS 8525, Institut Pasteur de Lille et Faculté des Sciences Pharmaceutiques et Biologiques, 3 rue du Professeur Laguesse, F-59006 LILLE Cedex France. rpoulain@pharma.univ-lille2.fr

The purpose of this review is to provide an update on our work based on the 1,4-bis(3-aminopropyl)piperazine skeleton and how it allowed our group to validate a new target. After a brief introduction where we will relate the way this substructure was introduced in our 4-aminoquinolinyl derivatives, we will present first the different libraries synthesized around this moiety: (1) libraries of sulfonamides, amides and amines derived from 4-aminoquinolines and, (2) libraries where the 4-aminoquinoline nucleus is replaced. High throughput evaluation of biological activity and physicochemical parameters will be presented. The evaluation of the anti-malarial activity of the compounds will be discussed in the light of a chloroquine-like mechanism (accumulation in the acidic food vacuole and inhibition of beta-hematin formation). In a second part we will present active 1,4-bis(3-aminopropyl)piperazine as tools for identification and/or validation of new antimalarial targets. Fluorescence assays on some derivatives show that they are surprisingly localized outside the food vacuole, suggesting the existence of other target(s). Secondly, we will present a library of 1,4-bis(3-aminopropyl)piperazine as inhibitors of the cytosolic aminopeptidase Pfa-M1, a new potential target for antimalarials.

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial

Related Publications

Rébecca Deprez-Poulain, and Patricia Melnyk
November 2003, Bioorganic & medicinal chemistry letters,
Rébecca Deprez-Poulain, and Patricia Melnyk
January 2005, Bioorganic & medicinal chemistry letters,
Rébecca Deprez-Poulain, and Patricia Melnyk
January 2000, Bioorganic & medicinal chemistry,
Rébecca Deprez-Poulain, and Patricia Melnyk
January 2012, Bioinorganic chemistry and applications,
Rébecca Deprez-Poulain, and Patricia Melnyk
November 2009, Journal of hazardous materials,
Rébecca Deprez-Poulain, and Patricia Melnyk
February 2009, Journal of enzyme inhibition and medicinal chemistry,
Rébecca Deprez-Poulain, and Patricia Melnyk
May 2016, Acta crystallographica. Section E, Crystallographic communications,
Rébecca Deprez-Poulain, and Patricia Melnyk
July 2012, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!